Glutamate nanoregulator for metabolic immunotherapy of biofilm-associated implant infections

Key Points

• Implant infections significantly improve with a glutamate nanoregulator, showing promising metabolic effects on biofilms.
• Key evidence indicates a marked reduction in infection rates observed with glutamate intervention in biofilm settings.
• Assessment using a novel glutamate nanoregulator highlights its role in metabolic immunotherapy against persistent infections.
• These findings suggest a useful shift in treatment strategies for implant infections caused by biofilms.